Xtant Medical (XTNT) Earnings Date, Estimates & Call Transcripts $0.53 0.00 (0.00%) (As of 11/4/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort Interest Xtant Medical Latest Earnings SummaryLatest Earnings DateAug. 8EstimatedActual EPS (Aug. 8) -$0.03 Missed By -$0.01 Consensus EPS (Aug. 8) -$0.02 Xtant Medical announced Q2 2024 earnings on August 8, 2024, reporting an EPS of -$0.03, which missed analysts' consensus estimates of -$0.02 by $0.01. Quarterly revenue was reported to be $29.94 million. Xtant Medical currently has a trailing EPS of -$0.02Conference Call TranscriptConference Call Audio Get Xtant Medical Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Xtant Medical and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataXTNT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.XTNT Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad TradingTipsTop 10 AI Stocks to Buy NowAre you ready to capitalize on the booming AI market? Our experts have identified the top 10 AI stocks set to skyrocket.Download our free report today Xtant Medical Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks8/8/2024--$0.02-$0.03 -$0.01-$0.03-$29.94M 5/15/2024Q1 2024--$0.03 -$0.03-$0.03-$27.87M 4/1/2024Q4 2023--$0.03 -$0.03-$0.03-$28.11M11/9/2023Q3 2023-$0.07+$0.07$0.07-$25.02M 8/1/2023Q2 2023--$0.02 -$0.02-$0.02-$20.23M 5/4/2023Q1 2023--$0.02 -$0.02-$0.02-$17.94M Get the Latest News and Ratings for XTNT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Xtant Medical and its competitors with MarketBeat's FREE daily newsletter. 3/7/2023Q4 2022--$0.02 -$0.02-$0.02-$15.27M ` More Earnings Resources from MarketBeat Related Companies Atea Pharmaceuticals Earnings Fate Therapeutics Earnings Inozyme Pharma Earnings Heron Therapeutics Earnings Ayr Wellness Earnings Sutro Biopharma Earnings TScan Therapeutics Earnings Lexeo Therapeutics Earnings Acrivon Therapeutics Earnings MacroGenics Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings ReportPulteGroup Earnings Signal Potential Entry Points for InvestorsTaiwan Semiconductor Soars on Earnings With More Room to Run Top 10 AI Stocks to Buy Now (Ad)Are you ready to capitalize on the booming AI market? Our experts have identified the top 10 AI stocks set to skyrocket.Download our free report today This page (NYSEAMERICAN:XTNT) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xtant Medical Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Xtant Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
